Skip to the page

Data / Form D filings / CyMon Bio, Inc.

CyMon Bio, Inc.: Form D filing

CyMon Bio, Inc., a technology company in Agoura Hills, CA, filed a Form D with the SEC in 2024. The latest, on February 12, 2024, reports $921,790 sold of a $2 million offering to 9 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
5627 KANAN ROAD, SUITE 486, Agoura Hills, CA, 91301
Phone
(682) 292-8090
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2023
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2010588

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 12, 2024New notice$2,000,000$921,790$1,078,2109Jan 29, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Thomas H Bliss, Jr.Executive Officer, Director
Keith H GreenfieldExecutive Officer, Director

Other technology companies in California that filed recently

Every Form D from the week of Feb 12, 2024 · All recent filings in California · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what CyMon Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.